Acid Peptic Disease-An oral administration of siddha classical drug Haritaki Kashayam

Assessment of Effectiveness of Haritaki Kashayam in the treatment of Eri Gunmam (Acid Peptic Disease) among patients attending OPD,Government Siddha Medical College and Hospital,Palayamkottai-A case series - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070118

Enrollment

Registered

2024-07-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K279- Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation

Interventions

Intervention1: Haritaki Kashayam: Dosage - 50ml (Twice a day orally) for 30 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: The Patients with symptoms of Epigastric burning,Heart burn,Bleching,Abdominal pain,Abdominal bloating. H/O of NSAID administration

Exclusion criteria

Exclusion criteria: Prenancy and Lactation CA stomach Appendicitis Acute pancreatitis Cholelithiasis

Design outcomes

Primary

Measure	Time frame
Prognosis of disease is assessed by reduction in clinical symptoms after the treatment by using GSRS (Gastrointestinal Symptoms Rating Scale) ScoreTimepoint: 15 days	—

Secondary

Measure	Time frame
The secondary outcome will be the observation of siddha diagnostic parametersTimepoint: 15 days	—

Countries

India

Contacts

Public ContactProf Dr T Komalavalli

Government Siddha Medical College and Hospital,Palayamkottai

komalaarumugam1@gmail.com8248497477

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026